Skip to content
  • Home
  • JCAD Online
  • Contact Us
  • Home
  • JCAD Online
  • Contact Us

Category: Maui Derm 2023 Meeting Coverage

Neal Bhatia, MD: New Therapies in the Field of Dermatology

Dr. Bhatia reviews an array of new therapies discussed during his New Drugs and Therapies presentation at Maui Derm 2023.

Neal Bhatia, MD: New Opportunities for JAK Inhibitors

Dr. Bhatia gives an overview of the utilization of JAK inhibitors in diseases such as hidradenitis suppurativa, vitiligo, alopecia areata, psoriasis, and atopic dermatitis.

Neal Bhatia, MD: Ritlecitinib as an Emerging Therapy for Alopecia Areata

Dr. Bhatia details the recent approval of Ritlecitinib which is launching soon for the treatment of alopecia areata.

Linda Stein Gold, MD: Exploring the Impact of Novel TYK2 Inhibitors in Plaque Psoriasis​

Dr. Stein Gold discusses her presentation at Maui Derm 2023 which focused on new TYK2 inhibitors for the treatment of plaque psoriasis, along with other exciting drugs on the horizon.

Linda Stein Gold, MD: Biggest Misconceptions Regarding Mild-to-Moderate Psoriasis​

Dr. Stein Gold discusses various misconceptions of localized psoriasis and stresses that topical therapy remains the mainstay of treatment for this disease.

← Previous
Next →
JCAD | The Journal of Clinical and Aesthetic Dermatology
  • Home
  • JCADOnline
  • Contact Us
  • Terms of Usage and Privacy Policies
  • Home
  • JCADOnline
  • Contact Us
  • Terms of Usage and Privacy Policies


©2025 JCAD | The Journal of Clinical and Aesthetic Dermatology. All Rights Reserved.

Facebook Twitter Instagram Envelope